Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hypoglycemia
Phenotype C0011854|type 1 diabetes
Sentences 161
PubMedID- 20536956 Case report: a 27-year-old man with type 1 diabetes suffered an episode of nocturnal hypoglycaemia which provoked a tonic-clonic seizure.
PubMedID- 22892724 Here, we tested the hypothesis that this region is less activated during hypoglycemia in subjects with type 1 diabetes (t1dm) and hypoglycemia unawareness relative to controls.
PubMedID- 26019878 To our knowledge, we have, for the first time, demonstrated that it is possible to completely avoid acute and late-nocturnal hypoglycemia in type 1 diabetes, despite performing a prolonged bout of moderate-to-vigorous intensity running (expending ∼740 kcal and running 7.3 km) exercise in the evening.
PubMedID- 25683747 Conclusions: a weight-based protocol of 0.3 g/kg glucose appears more effective for treating symptomatic hypoglycaemia in adults with type 1 diabetes than either the most common current recommendation of 15 g glucose or a 0.2 g/kg glucose dose.
PubMedID- 21680991 Recognition, prevention, and proactive management of hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 24123789 The beta-cell replacement by islet transplantation is an attractive approach for normalizing blood glucose without hypoglycaemia in patient with type 1 diabetes mellitus (t1d).
PubMedID- 24589650 Objectives: the aim of this study was to investigate specific fears related to hypoglycemia in adults with type 1 diabetes and to investigate how aspects of fear of hypoglycemia may differ between genders.
PubMedID- 25016670 Patients with type 1 diabetes have an average of two symptomatic hypoglycemias in a week and at least one severe hypoglycemia in a year.
PubMedID- 22584135 Therefore, our data do not support the hypothesis that severe hypoglycemia in patients with type 1 diabetes increases the risk of cvd.
PubMedID- 23912765 hypoglycemia in patients with type 1 diabetes: epidemiology, pathogenesis, and prevention.
PubMedID- 25985748 Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes.
PubMedID- 24023652 Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.
PubMedID- 23577069 Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.
PubMedID- 22563248 The uk study group found that the incidence of severe hypoglycemia in patients with type 1 diabetes treated with insulin for >15 years was three times higher than in those treated for <5 years.
PubMedID- 23434929 Accordingly, the systemic administration of a somatostatin receptor agonist exacerbates severe hypoglycemia in patients with type 1 diabetes mellitus (29), likely because of reductions in glucose counterregulatory hormone levels to ensuing insulin-induced hypoglycemia.
PubMedID- 24574352 We asked: 1) what are the acute, temporal associations between mvpa and hypoglycemia in adolescents with type 1 diabetes and 2) are these associations moderated by sex, fitness, or adiposity?
PubMedID- 24736487 A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
PubMedID- 21747831 Recently, it was demonstrated that during spontaneous hypoglycemia in patients with type 1 diabetes, qtc interval can be moderately increased [44], whereas glucose-qtc association is reported to differ among individuals with type 1 diabetes.
PubMedID- 23514728 Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes.
PubMedID- 22047939 Aim: this study examines whether the short-term use of a continuous glucose monitor (cgm) can reduce the fear of hypoglycaemia in individuals with type 1 diabetes mellitus (t1dm).
PubMedID- 23266467 Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way.
PubMedID- 25415670 Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases.
PubMedID- 22371161 Continuous subcutaneous insulin infusion (csii, or insulin pump therapy) reduces hba1c levels and hypoglycaemia in patients with type 1 diabetes mellitus (t1dm) compared with multiple daily insulin injections (mdi).
PubMedID- 21299416 Feline responses to hypoglycemia in people with type 1 diabetes.
PubMedID- 21722581 Background: real-time continuous glucose monitoring (rt-cgm) improves hemoglobin a1c (a1c) and hypoglycemia in people with type 1 diabetes mellitus and those with type 2 diabetes mellitus (t2dm) on prandial insulin; however, it has not been tested in people with t2dm not taking prandial insulin.
PubMedID- 26213236 Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with type 1 diabetes.
PubMedID- 25986629 We investigated known and potential risk factors for hypoglycemia in subjects with type 1 diabetes.
PubMedID- 25053587 We studied the effects of gip and glp-1 on glucagon responses to insulin-induced hypoglycemia in patients with type 1 diabetes mellitus (t1dm).
PubMedID- 24057153 This is the first study to examine how the ultra-long-acting basal insulin ideg (estimated duration of action >42 h) affects the hypoglycaemic response during development of, and recovery from, hypoglycaemia in patients with type 1 diabetes.
PubMedID- 21346182 Conclusions: the hfs-ii is a reliable and valid measure of the fear of hypoglycemia in adults with type 1 diabetes, and factor analyses and irt support the two separate subscales of the survey.
PubMedID- 20007944 These data suggest that initiation of insulin analog treatment preconception rather than during early pregnancy may result in a lower risk of severe hypoglycemia in women with type 1 diabetes.
PubMedID- 22175008 This pilot data suggests that gln supplementation increases the likelihood of postexercise overnight hypoglycaemia in adolescents with type 1 diabetes.
PubMedID- 22357303 Studies on nutritional strategies to prevent exercise-induced hypoglycemia in adolescents with type 1 diabetes are scarce.
PubMedID- 23589542 Event rates for severe hypoglycemia for patients with type 1 diabetes range from 115 (24) to 320 (23) per 100 patient-years.
PubMedID- 24654672 It has been estimated that the incidence rate for emergency treatment of severe hypoglycaemia in people with type 1 diabetes is ˜11.5 per 100 patients-years 11. in that study, the associated cost was estimated to be ˜£6.5 m across the uk.
PubMedID- 20587723 Thus, at least two separate mechanisms for increasing thrombosis are activated by hypoglycemia in individuals with type 1 diabetes and healthy individuals.
PubMedID- 23855268 Caffeine intake has also been proposed to increase symptomatic warning signs of hypoglycemia in patients with type 1 diabetes and elevate blood glucose levels in patients with type 2 diabetes.
PubMedID- 26345338 Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: a randomized clinical trial.
PubMedID- 21443586 Objective: to determine the most effective of four oral treatments for hypoglycemia in children with type 1 diabetes using a weight-based protocol during diabetes camp.
PubMedID- 21323815 Improvements in real-time continuous glucose monitoring and optimisation of basal insulin dosing may offer significant benefit to preventing hypoglycaemia in patients with type 1 diabetes who regularly exercise.
PubMedID- 23781301 Association of igf1 with glycemic control and occurrence of severe hypoglycemia in patients with type 1 diabetes mellitus.
PubMedID- 24804697 A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes.
PubMedID- 26141615 Therefore, we hypothesized that heart rate variability (hrv) and baroreflex sensitivity (brs) would be reduced during hypoglycemia in adults with type 1 diabetes, with a further decline when combined with hypoxia.
PubMedID- 26312919 Results from hospital-based studies have shown improved overnight glucose control and reduced risk of hypoglycaemia in type 1 diabetes.
PubMedID- 19663922 Objective: there is a lack of evidence regarding the most effective treatment option for managing naturally occurring hypoglycemia in children with type 1 diabetes.
PubMedID- 26354059 Recently, one study reported alterations of all electrolytes during insulin induced hypoglycemia in patients with type 1 diabetes.
PubMedID- 24122616 The performance of the proposed r-bbnn algorithm was evaluated by an application to the field of medical diagnosis using real hypoglycemia episodes in patients with type 1 diabetes mellitus.
PubMedID- 20546285 Frequency of biochemical hypoglycaemia in adults with type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring.
PubMedID- 21246006 For this reason, the american association of clinical endocrinologists has recommended the use of personal devices for glucose control and prevention of hypoglycemia in patients with type 1 diabetes [2,3] and pregnancy with diabetes [4,5].
PubMedID- 21493665 Conclusion these two small crossover trials suggest that closed loop delivery of insulin may improve overnight control of glucose levels and reduce the risk of nocturnal hypoglycaemia in adults with type 1 diabetes.

Page: 1 2 3 4